What is the worldwide prevalence of myopia overall and the proportion of low‑grade (‑0.50 D to ‑3.00 D), moderate‑grade (‑3.00 D to ‑5.00 D), and high‑grade (≤‑5.00 D) myopia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Global Prevalence of Myopia by Severity Grade

The worldwide prevalence of myopia is approximately 26.5% in adults and 11.7% in children, with high myopia (≤-5.00 D) affecting 7.4% of myopic populations, though specific proportions for low-grade and moderate-grade myopia are not consistently reported across global epidemiological studies. 1

Overall Global Prevalence

The global burden of myopia varies substantially by age and geography:

  • Adults (age 40+): Overall myopia prevalence ranges from 25-36% in U.S. populations, with Chinese Americans showing 35.1% prevalence (≥-0.50 D) 1
  • Children and adolescents: Global prevalence is 11.7%, though this masks dramatic regional variation from 4.9% in South-East Asia to 18.2% in the Western Pacific region 1
  • Projected trends: Meta-analyses predict myopia prevalence will reach 49.8% globally by 2050, affecting nearly half the world's population 2

High Myopia Prevalence (≤-5.00 D)

High myopia represents the most clinically significant category due to associated vision-threatening complications:

  • Among Chinese Americans aged 50+, high myopia (≤-5.00 D) affects 7.4% of the population 1
  • Global projections estimate high myopia will increase from 2.7% (2000) to 9.8% by 2050 2
  • In Chinese populations specifically, high myopia prevalence in school-aged children ranges from 8.89% in middle school to 20.12% in high school students 3

Low and Moderate Myopia Distribution

The evidence base provides limited specific breakdowns by the requested severity categories, but available data suggests:

  • In Weifang, China, among students: low myopia (-0.75 to -3.00 D) affects 48.56% of elementary students, 47.30% of middle school students, and 31.62% of high school students 3
  • Moderate myopia (-3.01 to -5.99 D) data is rarely reported separately in epidemiological studies, representing a gap in the literature 3
  • The majority of myopic individuals fall into the low-to-moderate range, as high myopia consistently represents less than 10% of total myopia cases globally 1, 2

Critical Geographic and Demographic Variations

East Asian populations demonstrate dramatically higher prevalence across all severity grades:

  • Taiwan: 84% of 16-18 year-olds have myopia, with 77% of 12-year-olds affected 1
  • Singapore: 79% of 18-year-old males and 85% of medical students (ages 19-23) have myopia 1
  • Korea: 71% prevalence in ages 19-49 1
  • Japan: 41.8-50% in adults aged 40+, with increasing trends from 38% (2005) to 46% (2017) 1

In contrast, Western populations show lower rates:

  • United States: 25-36% in adults aged 20-40+, with ethnic variations (higher in non-Hispanic whites and Asian/Pacific Islanders) 1
  • Australia: 16-29% in adults aged 49-70 years 1
  • Europe: Netherlands shows 2.4% in 6-year-olds; Ireland 3.3% in 6-7 year-olds, rising to 20% by ages 12-13 1

Important Methodological Considerations

A critical caveat affects all prevalence estimates:

  • Cycloplegic vs. non-cycloplegic refraction produces substantially different results—one study in Inner Mongolia found 77% myopia prevalence without cycloplegia versus 54% with cycloplegia 1
  • Myopia definitions vary between studies (≥-0.50 D vs. ≥-0.75 D), making direct comparisons challenging 1, 3
  • The lack of standardized severity grading across studies limits precise global estimates for moderate myopia specifically 3

Age-Related Patterns

Myopia prevalence demonstrates consistent age-related progression:

  • Childhood onset: 3% in ages 5-7, increasing to 8% in ages 8-10, and 14% in ages 11-12 in U.S. populations 1
  • Fastest progression occurs between ages 7-9 years 3
  • Adult prevalence peaks in 20s-40s (35-40%), then decreases in older adults (15-20% in 60s-80s) due to cohort effects and nuclear sclerosis-related myopic shifts 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.